Yunsheng He

2.1k total citations · 1 hit paper
20 papers, 823 citations indexed

About

Yunsheng He is a scholar working on Molecular Biology, Pharmacology and Genetics. According to data from OpenAlex, Yunsheng He has authored 20 papers receiving a total of 823 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Molecular Biology, 4 papers in Pharmacology and 4 papers in Genetics. Recurrent topics in Yunsheng He's work include Cholinesterase and Neurodegenerative Diseases (4 papers), Alzheimer's disease research and treatments (3 papers) and Computational Drug Discovery Methods (3 papers). Yunsheng He is often cited by papers focused on Cholinesterase and Neurodegenerative Diseases (4 papers), Alzheimer's disease research and treatments (3 papers) and Computational Drug Discovery Methods (3 papers). Yunsheng He collaborates with scholars based in United States, Switzerland and Canada. Yunsheng He's co-authors include Roger Lane, Howard Bergman, Roger Bullock, Giuseppe Gambina, Jacques Touchon, Brian K. Kay, Dana M. Fowlkes, Nils B. Adey, John P. Manfredi and Paul M. Ridker and has published in prestigious journals such as Circulation, Human Molecular Genetics and The British Journal of Psychiatry.

In The Last Decade

Yunsheng He

18 papers receiving 788 citations

Hit Papers

TET2-Driven Clonal Hemato... 2022 2026 2023 2024 2022 50 100 150 200

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Yunsheng He United States 11 305 217 163 141 127 20 823
Mylène Pouliot Canada 15 177 0.6× 54 0.2× 53 0.3× 35 0.2× 201 1.6× 39 606
Anita K. Salyers United States 16 202 0.7× 309 1.4× 247 1.5× 233 1.7× 30 0.2× 21 942
Anna Zacco United States 6 418 1.4× 79 0.4× 154 0.9× 21 0.1× 22 0.2× 9 798
Fernand Gobeil Canada 18 342 1.1× 109 0.5× 153 0.9× 36 0.3× 129 1.0× 23 907
Anne Marilise Marrache Canada 11 361 1.2× 85 0.4× 137 0.8× 23 0.2× 113 0.9× 16 740
Martin Beauchamp Canada 19 464 1.5× 136 0.6× 202 1.2× 37 0.3× 235 1.9× 23 1.2k
Yoo Jin Jung South Korea 17 550 1.8× 52 0.2× 109 0.7× 28 0.2× 60 0.5× 25 1.3k
Mee Young Chang United States 14 370 1.2× 51 0.2× 131 0.8× 15 0.1× 26 0.2× 17 944
Kimberly Umans United States 7 107 0.4× 110 0.5× 301 1.8× 21 0.1× 18 0.1× 12 582
Christine Bétard Canada 21 445 1.5× 35 0.2× 239 1.5× 34 0.2× 13 0.1× 22 1.1k

Countries citing papers authored by Yunsheng He

Since Specialization
Citations

This map shows the geographic impact of Yunsheng He's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yunsheng He with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yunsheng He more than expected).

Fields of papers citing papers by Yunsheng He

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yunsheng He. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yunsheng He. The network helps show where Yunsheng He may publish in the future.

Co-authorship network of co-authors of Yunsheng He

This figure shows the co-authorship network connecting the top 25 collaborators of Yunsheng He. A scholar is included among the top collaborators of Yunsheng He based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yunsheng He. Yunsheng He is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
2.
He, Yunsheng, et al.. (2024). Image motion analysis and compensation for dynamic push-broom imaging with TDI detectors. Applied Optics. 63(18). 4819–4819. 2 indexed citations
3.
He, Yunsheng, et al.. (2024). Development and validation of survival nomograms for patients with anaplastic thyroid carcinoma: a SEER program-based study. Discover Oncology. 15(1). 650–650. 1 indexed citations
4.
Burstedt, Marie, Jane S. Green, Karen Holopigian, et al.. (2023). Retinal Dystrophy Associated With RLBP1 Retinitis Pigmentosa: A Five-Year Prospective Natural History Study. Investigative Ophthalmology & Visual Science. 64(13). 42–42. 4 indexed citations
5.
He, Yunsheng, et al.. (2023). Analysis of image motion for optical remote sensing satellites staring imaging with area-array detectors. Applied Optics. 62(10). 2470–2470. 2 indexed citations
6.
Svensson, E. C., Aviv Madar, Catarina D. Campbell, et al.. (2022). TET2-Driven Clonal Hematopoiesis and Response to Canakinumab. JAMA Cardiology. 7(5). 521–521. 218 indexed citations breakdown →
7.
Xie, Jiaqing, et al.. (2020). Study on the liquid crystal display mask photo‐curing of photosensitive resin reinforced with graphene oxide. Journal of Applied Polymer Science. 137(47). 6 indexed citations
8.
Svensson, E. C., Aviv Madar, Catarina D. Campbell, et al.. (2018). Abstract 15111: TET2-Driven Clonal Hematopoiesis Predicts Enhanced Response to Canakinumab in the CANTOS Trial: An Exploratory Analysis. Circulation. 32 indexed citations
9.
Stacy, Rebecca C., Kenneth Huttner, James H. Peace, et al.. (2018). A Randomized, Controlled Phase I/II Study to Evaluate the Safety and Efficacy of MGV354 for Ocular Hypertension or Glaucoma. American Journal of Ophthalmology. 192. 113–123. 13 indexed citations
10.
Jacquemont, Sébastien, Laura Pacini, Aia Elise Jønch, et al.. (2018). Protein synthesis levels are increased in a subset of individuals with fragile X syndrome. Human Molecular Genetics. 27(12). 2039–2051. 48 indexed citations
11.
Green, Jane, Marie Burstedt, Yunsheng He, et al.. (2017). Baseline characteristics of patients with RLBP1 retinitis pigmentosa enrolled in a prospective Natural History Study. 58(8). 3254–3254. 1 indexed citations
12.
Mueller, Arne, Sébastien Jacquemont, Florian Hahne, et al.. (2016). Reciprocal changes in DNA methylation and hydroxymethylation and a broad repressive epigenetic switch characterize FMR1 transcriptional silencing in fragile X syndrome. Clinical Epigenetics. 8(1). 15–15. 15 indexed citations
13.
He, Yunsheng. (2013). Grid-Connected Fuzzy-PID Control of PV Power Generation System. 1 indexed citations
14.
Portes, Vincent des, Maria Giulia Torrioli, Elizabeth Berry‐Kravis, et al.. (2011). Epigenetic modification of the FMR1 gene in fragile X patients leads to a differential response to the mGluR5 antagonist AFQ056. 2 indexed citations
15.
Lane, Roger, Yunsheng He, Christopher M. Morris, et al.. (2008). BuChE‐K and APOE ϵ4 allele frequencies in Lewy body dementias, and influence of genotype and hyperhomocysteinemia on cognitive decline. Movement Disorders. 24(3). 392–400. 34 indexed citations
16.
Lane, Roger, Howard Feldman, Joanne M. Meyer, et al.. (2008). Synergistic effect of apolipoprotein E ε4 and butyrylcholinesterase K-variant on progression from mild cognitive impairment to Alzheimer's disease. Pharmacogenetics and Genomics. 18(4). 289–298. 44 indexed citations
17.
Bullock, Roger, Howard Bergman, Jacques Touchon, et al.. (2006). Effect of age on response to rivastigmine or donepezil in patients with Alzheimer's disease. Current Medical Research and Opinion. 22(3). 483–494. 47 indexed citations
18.
Blesa, Rafael, Roger Bullock, Yunsheng He, et al.. (2006). Effect of butyrylcholinesterase genotype on the response to rivastigmine or donepezil in younger patients with Alzheimer's disease. Pharmacogenetics and Genomics. 16(11). 771–774. 49 indexed citations
19.
Bullock, Roger, Jacques Touchon, Howard Bergman, et al.. (2005). Rivastigmine and donepezil treatment in moderate to moderately-severe Alzheimer's disease over a 2-year period. Current Medical Research and Opinion. 21(8). 1317–1327. 169 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026